Lactate Dehydrogenase (LDH) Activity Analysis: Principles, Methods, and Applications

Lactate dehydrogenase (LDH) activity analysis is a quantitative enzymatic assay that measures the catalytic conversion of lactate to pyruvate in biological, pharmaceutical, and food samples. As a sensitive biomarker of tissue damage, cytotoxicity, and product quality, LDH testing supports clinical diagnosis, drug safety evaluation, and bioprocess monitoring. Accredited third-party laboratories perform LDH activity analysis in accordance with internationally recognized standards such as IFCC, CLSI, ISO 15189, and ISO/IEC 17025.

Technical Overview

Lactate dehydrogenase (LDH, EC 1.1.1.27) is a cytoplasmic oxidoreductase that catalyzes the reversible interconversion of pyruvate and L-lactate, using nicotinamide adenine dinucleotide (NAD+/NADH) as a coenzyme. The enzyme functions as a tetramer assembled from two distinct subunit types—the heart-type (H) and muscle-type (M) polypeptides—giving rise to five isoenzymes (LDH-1 through LDH-5) with tissue-specific distribution.

Because LDH is abundantly present in the heart, liver, skeletal muscle, kidney, lung, erythrocytes, and tumor tissues, elevated LDH activity in serum or other body fluids serves as a non-specific but clinically valuable indicator of cellular injury, hemolysis, inflammation, hypoxia, and malignancy. Enzyme activity is conventionally expressed in units per liter (U/L), where one unit corresponds to the conversion of one micromole of substrate per minute under defined conditions. Modern LDH activity analysis relies primarily on kinetically monitored ultraviolet (UV) spectrophotometry at 340 nm, following internationally harmonized reference procedures recommended by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).

Testing Samples

Clinical and Biological Specimens

Serum, heparinized or EDTA plasma, cerebrospinal fluid, pleural fluid, peritoneal fluid, and other body fluids are routinely analyzed for total LDH activity and isoenzyme distribution. Samples must be free of hemolysis, since erythrocytes contain high LDH concentrations that can falsely elevate results.

Cell Culture and Cytotoxicity Samples

Cell lysates and conditioned culture supernatants are widely submitted for LDH release assays, a standard approach for quantifying cytotoxicity in immunotherapy, oncology, and drug safety studies. Supernatant LDH activity is proportional to the number of cells with compromised membrane integrity.

Tissue and Organ Homogenates

Preclinical tissue specimens, organ homogenates, and animal model samples are analyzed to evaluate tissue injury, metabolic status, and pharmacological or toxicological effects in preclinical studies.

Food, Fermentation, and Enzyme Products

Dairy products, meat products, fruit juices, fermentation broths, and commercial enzyme preparations are tested to verify process quality, assess microbial or endogenous enzyme activity, and confirm product consistency and stability.

Pharmaceutical and Biopharmaceutical Materials

Biologics, cell banks, wound care products, and diagnostic reagent components may be characterized for LDH activity as part of potency testing, quality control, and stability programs conducted by accredited third-party laboratories.

Testing Items

LDH activity analysis services typically encompass the following measurable parameters:

• Total LDH activity determination (U/L or U/mg protein) in biological fluids and extracts
• LDH isoenzyme profiling and fractionation (LDH-1 to LDH-5) by electrophoretic separation
• LDH release cytotoxicity quantification for cell-based potency and safety assays
• Specific activity and purity assessment of purified or recombinant LDH preparations
• Enzyme kinetic characterization, including Michaelis constant (Km) and maximum velocity (Vmax)
• Thermal stability, storage stability, and shelf-life evaluation of enzyme-containing products
• Method validation parameters such as linearity, precision, accuracy, limit of detection, and limit of quantification

Testing Methods

UV Kinetic Spectrophotometry (IFCC-Recommended Procedure)

The internationally preferred IFCC method measures the forward reaction in which L-lactate is oxidized to pyruvate with simultaneous reduction of NAD+ to NADH. The rate of NADH formation is monitored continuously as an increase in absorbance at 340 nm (molar absorptivity of NADH: 6.3 x 10³ L·mol⁻¹·cm⁻¹) at a standardized temperature of 37°C. This lactate-to-pyruvate direction offers superior analytical stability and substrate solubility.

Reverse-Direction (Pyruvate-to-Lactate) Assay

Alternatively, the reverse reaction monitors the oxidation of NADH to NAD+ as a decrease in absorbance at 340 nm. This approach is faster and remains in use in some regional pharmacopeial and national standard procedures, though it is more susceptible to substrate inhibition and requires carefully controlled pyruvate concentrations.

Colorimetric and Fluorometric Methods

For microplate-based cytotoxicity screening, coupled diaphorase-tetrazolium dye systems convert the NADH generated by LDH into colored formazan products measurable at approximately 490–520 nm. Fluorometric detection using resazurin-based coupling reagents provides enhanced sensitivity for low-activity samples and high-throughput formats.

Isoenzyme Electrophoresis

Agarose gel or cellulose acetate electrophoresis separates the five LDH isoenzymes based on charge differences, followed by activity staining. Isoenzyme patterns provide organ-specific diagnostic information, such as an elevated LDH-1/LDH-2 ratio suggesting myocardial injury.

Quality Assurance and Standards Compliance

Testing is performed under quality management systems conforming to ISO/IEC 17025 for general testing laboratories or ISO 15189 for medical laboratories, with reference to IFCC and CLSI methodological recommendations and applicable national standards (GB/T). Analytical runs incorporate calibrated instrumentation, traceable reference materials, appropriate controls, and participation in external quality assessment schemes to guarantee result reliability.

Applications

LDH activity analysis delivers actionable data across diverse industries and research disciplines:

• Clinical diagnostics: supporting evaluation of myocardial infarction, hemolytic anemia, hepatic disorders, muscular dystrophy, pulmonary embolism, and tumor burden monitoring
• Drug development: quantifying cytotoxicity of candidate compounds, antibody-drug conjugates, and cell therapy products via LDH release assays
• Bioprocess monitoring: tracking cell viability and lysis in mammalian cell culture and fermentation processes
• Food quality control: verifying pasteurization efficiency, assessing microbial contamination, and evaluating freshness of meat and dairy products
• Exercise physiology and sports science: interpreting training adaptation and muscle damage through serial LDH measurements
• Oncology research: investigating metabolic reprogramming and the Warburg effect in tumor models
• Environmental toxicology: evaluating cytotoxic effects of contaminants in in vitro test systems

FAQ

What sample volumes and handling conditions are required for LDH testing?

Typical UV kinetic assays require 20–100 microliters of serum, plasma, or supernatant. Samples should be collected and separated promptly, stored at 2–8°C for short-term analysis, or frozen at -70°C for longer storage. Repeated freeze-thaw cycles must be avoided to prevent activity loss.

Why is hemolysis a critical interference in LDH analysis?

Erythrocytes contain approximately 100–150 times higher LDH activity than serum. Even slight hemolysis releases intracellular enzyme and falsely elevates results, so visually hemolyzed specimens are generally rejected or flagged accordingly.

What is the difference between the two analytical reaction directions?

The lactate-to-pyruvate (forward) direction is the IFCC-recommended standard at 37°C and offers better reagent stability and linearity. The pyruvate-to-lactate (reverse) direction is faster but more sensitive to substrate concentration effects; both directions must be clearly identified when reporting results since they yield numerically different values.

How is cytotoxicity calculated from LDH release data?

Cytotoxicity is determined by comparing LDH activity in experimental wells against spontaneous release controls (untreated cells) and maximum release controls (fully lysed cells), expressed as a percentage of maximum release. This normalized format enables robust comparison across experiments.

What turnaround time and reporting format can be expected?

Standard LDH activity testing is typically completed within 3–7 working days, with expedited options available. Reports include measured activity values, method parameters, applicable quality control data, and interpretation guidance, issued by laboratories operating under ISO/IEC 17025 or ISO 15189 accredited quality systems.